Citations (73)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Panek Małgorzata, Kawalec Paweł, Malinowska Lipień Iwona, Tomasz Brzostek & Pilc Andrzej. (2020) Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets. Expert Opinion on Therapeutic Targets 24:12, pages 1187-1209.
Read now
Read now
Michael Hinchcliffe & Alan Smith. (2017) Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis. Degenerative Neurological and Neuromuscular Disease 7, pages 61-70.
Read now
Read now
Liang Peng, Baoman Li & Alexei Verkhratsky. (2016) Targeting astrocytes in bipolar disorder. Expert Review of Neurotherapeutics 16:6, pages 649-657.
Read now
Read now
Kyle AB Lapidus, Laili Soleimani & James W Murrough. (2013) Novel glutamatergic drugs for the treatment of mood disorders. Neuropsychiatric Disease and Treatment 9, pages 1101-1112.
Read now
Read now
Marco A Grados, Matt W Specht, Hyung-Mo Sung & Diandra Fortune. (2013) Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach. Expert Opinion on Drug Discovery 8:12, pages 1515-1527.
Read now
Read now
Susan L McElroy, Anna I Guerdjikova, Nicole Mori & Anne M O’Melia. (2012) Pharmacological management of binge eating disorder: current and emerging treatment options. Therapeutics and Clinical Risk Management 8, pages 219-241.
Read now
Read now
Sarah Biedermann, Wolfgang Weber-Fahr, Lei Zheng, Carolin Hoyer, Barbara Vollmayr, Peter Gass, Gabriele Ende & Alexander Sartorius. (2012) Increase of hippocampal glutamate after electroconvulsive treatment: A quantitative proton MR spectroscopy study at 9.4 T in an animal model of depression. The World Journal of Biological Psychiatry 13:6, pages 447-457.
Read now
Read now
Articles from other publishers (66)
Yoshitaka Kawashima, Misa Yamada, Hiroki Furuie, Hiroshi Kuniishi, Kie Akagi, Tomoko Kawashima, Takamasa Noda & Mitsuhiko Yamada. (2023) Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review. Neuropsychopharmacology Reports.
Crossref
Crossref
Siddhartha Datta, Zubin Rashid, Saptarnab Naskar & Sumantra Chattarji. (2023) Administration of the glutamate-modulating drug, riluzole, after stress prevents its delayed effects on the amygdala in male rats. PNAS Nexus 2:6.
Crossref
Crossref
Alexander P. Voronin, Artem O. Surov, Andrei V. Churakov & Mikhail V. Vener. (2023) Supramolecular Organization in Salts of Riluzole with Dihydroxybenzoic Acids—The Key Role of the Mutual Arrangement of OH Groups. Pharmaceutics 15:3, pages 878.
Crossref
Crossref
Elif Nur Barut, Seckin Engin, Yesim Kaya Yasar & Sena F. Sezen. (2023) Riluzole, a neuroprotective agent, preserves erectile function following bilateral cavernous nerve injury in male rats. International Journal of Impotence Research.
Crossref
Crossref
Dobrina Tsvetkova, Stefka Ivanova & Danka Obreshkova. (2023) Neurodegenerative Multioethiology Lou Gehrig’s Disease – Genetic Mutations, Pharmacological Mechanisms and Applications of Rilusole. International Journal of Pharmaceutical Research and Allied Sciences 12:3, pages 61-70.
Crossref
Crossref
Yaxiong Yang, Miao Wei & Lei Chen. (2022) Structural identification of riluzole-binding site on human TRPC5. Cell Discovery 8:1.
Crossref
Crossref
Elisa M.T. Melloni, Beatrice Bravi, Sara Poletti, Sara Dallaspezia, Barbara Barbini, Raffaella Zanardi & Francesco Benedetti. (2022) Antidepressant chronotherapeutics normalizes prefrontal 1H-MRS glutamate in bipolar depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 119, pages 110606.
Crossref
Crossref
Atabak nikbakht, Saeed kargar_soleimanabad, Ali Siahposht-Khachaki & Davood Farzin. (2022) The effect of Riluzole on neurological outcomes, blood-brain barrier, brain water and neuroinflammation in traumatic brain injury. Brain Disorders 8, pages 100052.
Crossref
Crossref
Sohee Park, Changyu Kang, Jaejeong Kim, Sanghyun Ju, Jin-Wook Yoo, In-Soo Yoon, Min-Soo Kim, Jaewon Lee & Yunjin Jung. (2022) A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug. Molecular Pharmaceutics 19:11, pages 3784-3794.
Crossref
Crossref
Chih-Hung Lin, Po-Chang Shih & Guochuan Emil Tsai. 2022. Ketamine Revisited - New Insights into NMDA Inhibitors. Ketamine Revisited - New Insights into NMDA Inhibitors.
Sireesha Murala, Aditya Boddu & Pradeep C. Bollu. 2022. Neurochemistry in Clinical Practice. Neurochemistry in Clinical Practice
91
107
.
Sarah L. Boddy, Ilaria Giovannelli, Matilde Sassani, Johnathan Cooper-Knock, Michael P. Snyder, Eran Segal, Eran Elinav, Lynne A. Barker, Pamela J. Shaw & Christopher J. McDermott. (2021) The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Medicine 19:1.
Crossref
Crossref
Letizia Mazzini, Fabiola De Marchi, Elena Niccolai, Jessica Mandrioli & Amedeo Amedei. 2021. Amyotrophic Lateral Sclerosis. Amyotrophic Lateral Sclerosis
141
158
.
Mohammed A. Khedr, Khadiga M. Abu-Zied, Wafaa A. Zaghary, Ahmed S. Aly, Dina N. Shouman & Hesham Haffez. (2021) Novel thienopyrimidine analogues as potential metabotropic glutamate receptors inhibitors and anticancer activity: Synthesis, In-vitro, In-silico, and SAR approaches. Bioorganic Chemistry 109, pages 104729.
Crossref
Crossref
Sahil Malik, Ravinder Singh, Govind Arora, Akriti Dangol & Sanjay Goyal. (2021) Biomarkers of Major Depressive Disorder: Knowing is Half the Battle. Clinical Psychopharmacology and Neuroscience 19:1, pages 12-25.
Crossref
Crossref
Agnieszka Zelek-Molik, Bartosz Bobula, Anna Gądek-Michalska, Katarzyna Chorązka, Adam Bielawski, Justyna Kuśmierczyk, Marcin Siwiec, Michał Wilczkowski, Grzegorz Hess & Irena Nalepa. (2021) Psychosocial Crowding Stress-Induced Changes in Synaptic Transmission and Glutamate Receptor Expression in the Rat Frontal Cortex. Biomolecules 11:2, pages 294.
Crossref
Crossref
Chris Miller, Stephen Apple, Jeremy S. Paige, Tara Grabowsky, Oodaye Shukla, Wendy Agnese & Charlotte Merrill. (2021) Current and Future Projections of Amyotrophic Lateral Sclerosis in the United States Using Administrative Claims Data. Neuroepidemiology 55:4, pages 275-285.
Crossref
Crossref
Alexei Verkhratsky, Vladimir Parpura, Caterina Scuderi & Baoman Li. 2021. Astrocytes in Psychiatric Disorders. Astrocytes in Psychiatric Disorders
317
347
.
Zhenzhen Xu, Jianxiang Jiang, Shengyuan Xu, Zunchun Xie, Pei He, Shishi Jiang & Renshi Xu. (2020) Nerve Growth Factor is a Potential Treated Target in Tg(SOD1*G93A)1Gur Mice. Cellular and Molecular Neurobiology.
Crossref
Crossref
Claudia Vingerhoets, Desmond HY Tse, Mathilde van Oudenaren, Dennis Hernaus, Esther van Duin, Janneke Zinkstok, Johannes G Ramaekers, Jacobus FA Jansen, Grainne McAlonan & Therese van Amelsvoort. (2020) Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study. Journal of Psychopharmacology 34:8, pages 856-863.
Crossref
Crossref
A. Irem Sonmez, Ammar Almorsy, Laura B. Ramsey, Jeffrey R. Strawn & Paul E. Croarkin. (2020) Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations. Depression and Anxiety 37:8, pages 747-759.
Crossref
Crossref
Motataianu Anca, Andone Sebastian, Radu Cristina, Bajko Zoltan, Barcutean Laura, Balasa Adrian, Voidazan Septimiu, Stoian Adina & Maier Smaranda. (2020) Predictors of Depression in Caucasian Patients with Amyotrophic Lateral Sclerosis in Romania. Brain Sciences 10:8, pages 470.
Crossref
Crossref
Angelica Benavides-Serrato, Jacquelyn T. Saunders, Brent Holmes, Robert N. Nishimura, Alan Lichtenstein & Joseph Gera. (2020) Repurposing Potential of Riluzole as an ITAF Inhibitor in mTOR Therapy Resistant Glioblastoma. International Journal of Molecular Sciences 21:1, pages 344.
Crossref
Crossref
Hitoshi Sakurai, Christina Dording, Albert Yeung, Simmie Foster, Felipe Jain, Trina Chang, Nhi-Ha Trinh, Richard Bernard, Sean Boyden, Syed Z Iqbal, Samuel T Wilkinson, Sanjay J Mathew, David Mischoulon, Maurizio Fava & Cristina Cusin. (2019) Longer-term open-label study of adjunctive riluzole in treatment-resistant depression. Journal of Affective Disorders 258, pages 102-108.
Crossref
Crossref
J.N. de Boer, C. Vingerhoets, M. Hirdes, G.M. McAlonan, T.V. Amelsvoort & J.R. Zinkstok. (2019) Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis. Psychiatry Research 278, pages 294-302.
Crossref
Crossref
Z. Mokhtari, T. Baluchnejadmojarad, F. Nikbakht, J. Fahanik-Babaei & M. Roghani. (2019) Effect of Riluzole, a Glutamate Release Inhibitor, on Synaptic Plasticity in the Intrahippocampal Aβ Rat Model of Alzheimer’s Disease. Neurophysiology 51:4, pages 266-271.
Crossref
Crossref
Mohammad-Hadi Farahzadi, Ehsan Moazen-Zadeh, Emran Razaghi, Mohammad-Reza Zarrindast, Reza Bidaki & Shahin Akhondzadeh. (2018) Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial. Journal of Psychopharmacology 33:3, pages 305-315.
Crossref
Crossref
Eduardo Octaviano Primini, José Luiz Liberato, Andreia Cristina Karklin Fontana & Wagner Ferreira dos Santos. (2019) Neuroprotective properties of RT10, a fraction isolated from Parawixia bistriata spider venom, against excitotoxicity injury in neuron-glia cultures. Journal of Venomous Animals and Toxins including Tropical Diseases 25.
Crossref
Crossref
Marcos Emilio Frizzo. (2019) The Effect of Glutamatergic Modulators on Extracellular Glutamate: How Does this Information Contribute to the Discovery of Novel Antidepressants?. Current Therapeutic Research 91, pages 25-32.
Crossref
Crossref
Débora Lanznaster, Denis Reis de Assis, Philippe Corcia, Pierre-François Pradat & Hélène Blasco. (2018) Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS. Frontiers in Neurology 9.
Crossref
Crossref
Irem Damla Cimen. 2018. Cognitive Behavioral Therapy and Clinical Applications. Cognitive Behavioral Therapy and Clinical Applications.
Shintaro Ogawa, Miho Ota, Jun Ogura, Koichi Kato & Hiroshi Kunugi. (2017) Effects of l-theanine on anxiety-like behavior, cerebrospinal fluid amino acid profile, and hippocampal activity in Wistar Kyoto rats. Psychopharmacology 235:1, pages 37-45.
Crossref
Crossref
Paul Grant, Cristan Farmer, Jane Song, Timothy Kish & Susan Swedo. (2017) Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology 37:6, pages 713-716.
Crossref
Crossref
Zahra Mokhtari, Tourandokht Baluchnejadmojarad, Farnaz Nikbakht, Monireh Mansouri & Mehrdad Roghani. (2017) Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer’s disease and is independent of cholinoceptor activation. Biomedicine & Pharmacotherapy 87, pages 135-144.
Crossref
Crossref
Foroozan Hasanpour, Mohsen Nekoeinia & Zeinab Razavipour. (2017) Reduced Graphene Oxide/Azo Naphthol Derivative Modified Glassy Carbon Electrode for Sensitive Electroanalysis of Riluzole. Journal of The Electrochemical Society 164:14, pages H989-H993.
Crossref
Crossref
Timo D. Vloet, Beate Herpertz-Dahlmann & Michael Simons. (2017) Neue Entwicklungen bei der psychotherapeutischen und pharmakologischen Behandlung der Zwangsstörung im Kindes- und Jugendalter. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 45:1, pages 9-22.
Crossref
Crossref
Alyssa N. Calder, Elliot J. Androphy & Kevin J. Hodgetts. (2016) Small Molecules in Development for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry 59:22, pages 10067-10083.
Crossref
Crossref
Elisse C. Browne & Belinda M. Abbott. (2016) Recent progress towards an effective treatment of amyotrophic lateral sclerosis using the SOD1 mouse model in a preclinical setting. European Journal of Medicinal Chemistry 121, pages 918-925.
Crossref
Crossref
Anand Gururajan, Gerard Clarke, Timothy G. Dinan & John F. Cryan. (2016) Molecular biomarkers of depression. Neuroscience & Biobehavioral Reviews 64, pages 101-133.
Crossref
Crossref
Elaheh Salardini, Atefeh Zeinoddini, Payam Mohammadinejad, Mohammad-Reza Khodaie-Ardakani, Nagmeh Zahraei, Arefeh Zeinoddini & Shahin Akhondzadeh. (2016) Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research 75, pages 24-30.
Crossref
Crossref
Carlos H. Rojas-Fernandez. 2016. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents. Applied Clinical Pharmacokinetics and Pharmacodynamics of Psychopharmacological Agents
29
48
.
Steven T. Szabo & Charles B. Nemeroff. 2015. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
1253
1274
.
Yu Deng, Zhaofa Xu, Bin Xu, Wei Liu, Yangang Wei, Yuehui Li, Shu Feng & Tianyao Yang. (2014) Exploring Cross-Talk Between Oxidative Damage and Excitotoxicity and the Effects of Riluzole in the Rat Cortex After Exposure to Methylmercury. Neurotoxicity Research 26:1, pages 40-51.
Crossref
Crossref
Paul J Grant, Lisa A Joseph, Cristan A Farmer, David A Luckenbaugh, Lorraine C Lougee, Carlos A Zarate & Susan E Swedo. (2013) 12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder. Neuropsychopharmacology 39:6, pages 1453-1459.
Crossref
Crossref
Nuno Rodrigues, Khalil Bennis, Delphine Vivier, Vanessa Pereira, Franck C. Chatelain, Eric Chapuy, Hemantkumar Deokar, Jérôme Busserolles, Florian Lesage, Alain Eschalier & Sylvie Ducki. (2014) Synthesis and structure–activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel. European Journal of Medicinal Chemistry 75, pages 391-402.
Crossref
Crossref
Gustavo H. Vázquez, Ross J. Baldessarini & Leonardo Tondo. (2014) CO-OCCURRENCE OF ANXIETY AND BIPOLAR DISORDERS: CLINICAL AND THERAPEUTIC OVERVIEW. Depression and Anxiety 31:3, pages 196-206.
Crossref
Crossref
Mehdi Farokhnia, Maryam Sabzabadi, Hossein Pourmahmoud, Mohammad-Reza Khodaie-Ardakani, Seyed-Mohammad-Reza Hosseini, Habibeh Yekehtaz, Mina Tabrizi, Farzin Rezaei, Bahman Salehi & Shahin Akhondzadeh. (2013) A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia. Psychopharmacology 231:3, pages 533-542.
Crossref
Crossref
Ali Ghaleiha, Effat Mohammadi, Mohammad-Reza Mohammadi, Mehdi Farokhnia, Amirhossein Modabbernia, Habibeh Yekehtaz, Mandana Ashrafi, Elmira Hassanzadeh & Shahin Akhondzadeh. (2013) Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial. Pediatric Drugs 15:6, pages 505-514.
Crossref
Crossref
Baron Shopsin. (2013) The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatrica 25:2, pages 113-118.
Crossref
Crossref
Yongchao WuKajana SatkunendrarajahYang TengDiana S.-L. ChowJosef ButtigiegMichael G. Fehlings. (2013) Delayed Post-Injury Administration of Riluzole Is Neuroprotective in a Preclinical Rodent Model of Cervical Spinal Cord Injury. Journal of Neurotrauma 30:6, pages 441-452.
Crossref
Crossref
Chadi G. Abdallah, Jeremy D. Coplan, Andrea Jackowski, João R. Sato, Xiangling Mao, Dikoma C. Shungu & Sanjay J. Mathew. (2012) Riluzole effect on occipital cortex: A structural and spectroscopy pilot study. Neuroscience Letters 530:1, pages 103-107.
Crossref
Crossref
Jonathan J CherryElliot J Androphy. (2012) Therapeutic strategies for the treatment of spinal muscular atrophy. Future Medicinal Chemistry 4:13, pages 1733-1750.
Crossref
Crossref
Mohd. Amir, S. Asif, Israr Ali & Mohd. Zaheen Hassan. (2011) Synthesis of benzothiazole derivatives having acetamido and carbothioamido pharmacophore as anticonvulsant agents. Medicinal Chemistry Research 21:9, pages 2661-2670.
Crossref
Crossref
Daniel C. Mathews, Ioline D. Henter & Carlos A. ZarateJrJr. (2012) Targeting the Glutamatergic System to Treat Major Depressive Disorder. Drugs 72:10, pages 1313-1333.
Crossref
Crossref
Gislaine Z. Réus, Roberto B. Stringari, Gislaine T. Rezin, Daiane B. Fraga, Juliana F. Daufenbach, Giselli Scaini, Joana Benedet, Natália Rochi, Emílio L. Streck & João Quevedo. (2011) Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain. Journal of Neural Transmission 119:4, pages 481-491.
Crossref
Crossref
Jess Shatkin & Aron Janssen. 2012. Pharmacotherapy of Child and Adolescent Psychiatric Disorders. Pharmacotherapy of Child and Adolescent Psychiatric Disorders
365
397
.
Christopher Pittenger, Michael H. Bloch & Kyle Williams. (2011) Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment. Pharmacology & Therapeutics 132:3, pages 314-332.
Crossref
Crossref
Kenji Hashimoto. (2011) The role of glutamate on the action of antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:7, pages 1558-1568.
Crossref
Crossref
Yue W Webster, Ernst R Dow, Jacob Koehler, Ranga C Gudivada & Mathew J Palakal. (2011) Leveraging health social networking communities in translational research. Journal of Biomedical Informatics 44:4, pages 536-544.
Crossref
Crossref
Mami Tsuchioka, Kazue Hisaoka, Ryoya Yano, Chiyo Shibasaki, Naoto Kajiatani & Minoru Takebayashi. (2011) Riluzole-induced glial cell line-derived neurotrophic factor production is regulated through fibroblast growth factor receptor signaling in rat C6 glioma cells. Brain Research 1384, pages 1-8.
Crossref
Crossref
Mark C. Bellingham. (2011) A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?. CNS Neuroscience & Therapeutics 17:1, pages 4-31.
Crossref
Crossref
Romain–Daniel Gosselin, Richard M. O'Connor, Monica Tramullas, Marcela Julio–Pieper, Timothy G. Dinan & John F. Cryan. (2010) Riluzole Normalizes Early-Life Stress-Induced Visceral Hypersensitivity in Rats: Role of Spinal Glutamate Reuptake Mechanisms. Gastroenterology 138:7, pages 2418-2425.
Crossref
Crossref
Peethambaran Arun, John R. Moffett & Aryan M.A. Namboodiri. (2010) Riluzole decreases synthesis of N-acetylaspartate and N-acetylaspartylglutamate in SH-SY5Y human neuroblastoma cells. Brain Research 1334, pages 25-30.
Crossref
Crossref
Owen M. Wolkowitz, Elissa S. Epel, Victor I. Reus & Synthia H. Mellon. (2010) Depression gets old fast: do stress and depression accelerate cell aging?. Depression and Anxiety 27:4, pages 327-338.
Crossref
Crossref
Farhad Ghoddoussi, Matthew P. Galloway, Amruta Jambekar, Monica Bame, Richard Needleman & William S.A. Brusilow. (2010) Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS. Journal of the Neurological Sciences 290:1-2, pages 41-47.
Crossref
Crossref
Wojciech Zgrajka, Dorota Nieoczym, Mirosław Czuczwar, Jacek Kiś, Wojciech Brzana, Piotr Wlaź & Waldemar A. Turski. (2010) Evidences for pharmacokinetic interaction of riluzole and topiramate with pilocarpine in pilocarpine-induced seizures in rats. Epilepsy Research 88:2-3, pages 269-274.
Crossref
Crossref